• 1-631-372-1052
  • 45-1 Ramsey Road, Shirley, NY 11967, USA

Hematology

Hematology

Get A Free QuoteOr by Phone: 1-631-372-1052
Hematology

Clinical stage hematology research is a well-known and complex field that can be in trouble due to complex regulatory strategies and complex clinical research designs. However, the need for novel hematological disease therapies still remains urgent. CD BioSciences has extensive experience in designing hematological and clinical strategies, and regulatory activities. In order to help our clients achieve the best success in delivering new medical breakthroughs to the market, we provide pre-clinical and one-stop clinical phase I-IV package development services for our world-wide clients.

Hematology Theraprutic Area

CD BioSciences has collaborated with many sponsors on clinical research projects involving hematological diseases, covering the treatment of multiple therapeutic areas such as hyponatremia, red blood cell storage, and acute / chronic leukemia. Specifically, our clinical services for hematology project including study design, PK/PD analysis and modeling, interim analysis, adaptive clinical trial analysis, and clinical monitoring and management, statistical support. Other services include general consulting, chemical, manufacturing and control (CMC) consulting, and feasibility reports.

We have a road range of experience in the following indicatons
  • Hemophilia A and B
  • Von Willebrand Disease
  • Sickle Cell Disease
  • Atypical Hemolytic-uremic Syndrome (aHUS)
  • Refractory Hematologic Malignancies
  • Bone Marrow Transplant
  • Chronic Lymphocytic: Leukemia
  • Chronic Myeloid: Leukemia
  • Gleevec-resistant Chronic: Myelogenous Leukemia
  • Acute Lymphoblastic: Leukemia
  • Acute Myeloid Leukemia
  • Anaemia Following: Myelotoxic Therapy
  • Chronic Myelogenous Leukemia
  • Progressive B-cell Chronic Lymphocytic Leukemia
  • Acute Leukemia
  • Myelodysplasia
  • Indolent Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Non-Hodgkin's Lymphoma
  • Hemodialysis Graft Occlusion
  • Hemolytic Uremic Syndrome Renal (HUS)

Why Choose CD BioSciences?

We have hired some of the brightest people, who put all their deep expertise into clinical development, giving you confidence that we can successfully complete your research. We implement the latest innovative technologies for research in a variety of hematological indications. Whether you are new to clinical drug development or want to partner with us to achieve your next major breakthrough, you can benefit from our competitive advantages, including:

  • Hematology medical expert who provides strategy, education and practical leadership
  • Establish long-term relationships with successful, seasoned sponsors
  • Global Regulatory Affairs and Medical Writing Team
  • Integrated imaging and central laboratory services
  • Comprehensive understanding of complex situations
  • Expertise in innovative research design:adaptive trials
  • Proactively navigate rapidly evolving regulations
  • Speed up project timelines with early involvement

Explore Our Clinical Services for a Complete Picture by Stage:

CD BioSciences' scientists are dedicated to bringing together years of valuable experience to help our clients shorten the clinical trial journey. For further details, please don't hesitate to contact us.

Are you looking for a professional advisor for your trials?

Online Inquiry
×